Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.1.1 extracted from

  • Nagy, V.; Benltifa, M.; Vidal, S.; Berzsenyi, E.; Teilhet, C.; Czifrak, K.; Batta, G.; Docsa, T.; Gergely, P.; Somsak, L.; Praly, J.P.
    Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase (2009), Bioorg. Med. Chem., 17, 5696-5707.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(1S)-1,5-anhydro-D-glucitol-spiro[1.5]-3-(2-naphthyl)-1,4,2-oxathiazole
-
Oryctolagus cuniculus
(1S)-1,5-anhydro-D-glucitol-spiro[1.5]-3-(4-methoxyphenyl)-1,4,2-oxathiazole
-
Oryctolagus cuniculus

Organism

Organism UniProt Comment Textmining
Oryctolagus cuniculus
-
phosphorylase b
-

Source Tissue

Source Tissue Comment Organism Textmining
skeletal muscle
-
Oryctolagus cuniculus
-

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.00016
-
(1S)-1,5-anhydro-D-glucitol-spiro[1.5]-3-(2-naphthyl)-1,4,2-oxathiazole
-
Oryctolagus cuniculus
0.0082
-
(1S)-1,5-anhydro-D-glucitol-spiro[1.5]-3-(4-methoxyphenyl)-1,4,2-oxathiazole
-
Oryctolagus cuniculus